|
|
Zhengyu Luo, Yasushi Fujio, Yasuko Kureishi, Radu Daniel Rudic, Geraldine Daumerie, David Fulton, William C. Sessa, Kenneth Walsh
J Clin Invest. 2000;
106(4):493
doi:10.1172/JCI9419
Abstract |
Full text
| PDF

T
he serine/threonine protein kinase Akt (protein kinase B) phosphorylates endothelial cell nitric oxide synthase (eNOS) and enhances its ability to generate nitric oxide (NO). Because NO is an important regulator of vasomotor tone, we investigated whether Akt can regulate endothelium-dependent vasomotion in vivo using a rabbit femoral artery model of gene transfer. The endothelium of isolated femoral arteries was infected with replication-defective adenoviral constructs expressing β-galactosidase, constitutively-active Akt (myr-Akt), or dominant-negative Akt (dn-Akt). Femoral arteries transduced with myr-Akt showed a significant increase in resting diameter and blood flow, as assessed by angiography and Doppler flow measurements, respectively. L-NAME, an eNOS inhibitor, blocked myr-Akt–mediated vasodilatation. In contrast, endothelium-dependent vasodilatation in response to acetylcholine was attenuated in vessels transduced with dn-Akt, although these vessels showed normal responses to nitroglycerin, an endothelium-independent vasodilator. Similarly, relaxation of murine aorta ex vivo in response to acetylcholine, but not nitroglycerin, was inhibited by transduction of dn-Akt to the endothelium. These data provide evidence that Akt functions as key regulator of vasomotor tone in vivo.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
About CrossRef
| Title and authors |
Publication |
Year |
. |
Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteries
Luciana V. Rossoni, Mark Wareing, Camilla F. Wenceslau, Mahmood Al‑Abri, Chris Cobb, Clare Austin |
Clin Sci Colch |
2011 |
.
|
Regulation of arterial blood pressure by Akt1-dependent vascular relaxation
Jung Min Ha, Young Whan Kim, Dong Hyung Lee, Sung Ji Yun, Eun Kyoung Kim, In Jin, Ji Hyun Kim, Chi Dae Kim, Hwa Kyoung Shin, Sun Sik Bae |
J Mol Med-JMM |
2011 |
.
|
Akt signalling in health and disease
Ingeborg Hers, Emma E. Vincent, Jeremy M. Tavaré |
Cellular Signal |
2011 |
.
|
Walter N. Durán, Fabiola A. Sánchez, Jerome W. Breslin |
Comprehensive Physiology |
2011 |
.
|
Insulin-stimulated phosphorylation of endothelial nitric oxide synthase at serine-615 contributes to nitric oxide synthesis
Stuart A. Ritchie, Christine F. Kohlhaas, Alasdair R. Boyd, Krishna C. Yalla, Kenneth Walsh, John M. C. Connell, Ian P. Salt |
Biochem J |
2010 |
.
|
Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats
Daisuke Ito, Osamu Ito, Nobuyoshi Mori, Yoshikazu Muroya, Peng-yu Cao, Kenta Takashima, Masayuki Kanazawa, Masahiro Kohzuki |
J Hypertens |
2010 |
.
|
Metallothionein-III Provides Neuronal Protection through Activation of Nuclear Factor- B via the TrkA/Phosphatidylinositol-3 kinase/Akt Signaling Pathway
H. G. Kim, Y. P. Hwang, E. H. Han, C. Y. Choi, C.-Y. Yeo, J. Y. Kim, K. Y. Lee, H. G. Jeong |
Toxicol Sei |
2009 |
.
|
Akt1 is critical for acute inflammation and histamine-mediated vascular leakage
A. Di Lorenzo, C. Fernandez-Hernando, G. Cirino, W. C. Sessa |
Proc Natl Acad Sci U S A |
2009 |
.
|
Regulation of the expression of endothelial nitric oxide synthase and dysfunction of vascular endothelium in cardiovascular pathology
N. A. Kravchenko, N. V. Yarmysh |
Cytol Genet |
2008 |
.
|
Redox Control of Endothelial Function and Dysfunction: Molecular Mechanisms and Therapeutic Opportunities
Shane R. Thomas, Paul K. Witting, Grant R. Drummond |
Antioxidants & Redox Signaling |
2008 |
.
|
Akt Induces Apoptosis in Neuroblastoma Cells Expressing a C98X Vasopressin Mutant Following Autophagy Suppression
R. Castino, C. Thepparit, N. Bellio, D. Murphy, C. Isidoro |
J Neuroendocrinol |
2008 |
.
|
Phosphoinositide 3-kinase signalling in the vascular system
F. Morello, A. Perino, E. Hirsch |
cardiovas res |
2008 |
.
|
Akt is transferred to the nucleus of cells treated with apoptin, and it participates in apoptin-induced cell death
S. Maddika, G. H. Bay, T. J. Kroczak, S. R. Ande, S. Maddika, E. Wiechec, S. B. Gibson, M. Los |
Cell Prolif |
2007 |
.
|
Nitric oxide synthesis in the kidney: isoforms, biosynthesis, and functions in health
Bruce C Kone |
Sem Nephrol |
2004 |
.
|
Hepatocyte Growth Factor Stimulates Nitric Oxide Production through Endothelial Nitric Oxide Synthase Activation by the Phosphoinositide 3-Kinase/Akt Pathway and Possibly by Mitogen-Activated Protein Kinase Kinase in Vascular Endothelial Cells
Akira URUNO, Akira SUGAWARA, Hiroshi KANATSUKA, Shuji ARIMA, Yoshihiro TANIYAMA, Masataka KUDO, Kazuhisa TAKEUCHI, Sadayoshi ITO |
Hypertens Res |
2004 |
.
|
Attenuation of Small-for-Size Liver Graft Injury by FTY720: Significance of Cell-survival Akt Signaling Pathway
Yi Zhao, Kwan Man, Chung Mau Lo, Kevin T. Ng, Xian Liang Li, Chris K. Sun, Terence K. Lee, Xian Wei Dai, Sheung Tat Fan |
Am J Transplant |
2004 |
.
|
The Effect of Tumor Necrosis Factor-.ALPHA. on Tissue Specificity and Selectivity to Insulin Signaling
Koichi YAMAGUCHI, Katsuhiro HIGASHIURA, Nobuyuki URA, Hideyuki MURAKAMI, Masaya HYAKUKOKU, Masato FURUHASHI, Kazuaki SHIMAMOTO |
Hypertens Res |
2003 |
.
|
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
Joan Llevadot, Satoshi Murasawa, Yasuko Kureishi, Shigeki Uchida, Haruchika Masuda, Atsuhiko Kawamoto, Kenneth Walsh, Jeffrey M. Isner, Takayuki Asahara |
Journal Clinical Investigation |
2001 |
.
|
PPARα deficiency reduces insulin resistance and atherosclerosis in apoE-null mice
Karen Tordjman, Carlos Bernal-Mizrachi, Laura Zemany, Sherry Weng, Chu Feng, Fengjuan Zhang, Teresa C. Leone, Trey Coleman, Daniel P. Kelly, Clay F. Semenkovich |
Journal Clinical Investigation |
2001 |
.
|
|
|
|